Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Anti-Cancer Drug Design|September 29, 1999
Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agentsJ A Spicer, S A Gamage, G J Atwell, et al.Journal of Medicinal Chemistry|June 6, 1997
Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamideJ A Spicer, S A Gamage, G J Atwell, et al.Journal of Medicinal Chemistry|February 1, 1991
Potential antitumor agents. 62. Structure-activity relationships for tricyclic compounds related to the colon tumor active drug 9-oxo-9H-xanthene-4-acetic acidG W Rewcastle, G J Atwell, B D Palmer, et al.Journal of Medicinal Chemistry|July 8, 1999
Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agentsS A Gamage, J A Spicer, G J Atwell, et al.Journal of Medicinal Chemistry|September 1, 1991
Potential antitumor agents. 63. Structure-activity relationships for side-chain analogues of the colon 38 active agent 9-oxo-9H-xanthene-4-acetic acidG W Rewcastle, G J Atwell, B C Baguley, et al.Anti-Cancer Drug Design|October 1, 1996
Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductaseG J Atwell, M Boyd, B D Palmer, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Induction of natural killer activity by xanthenone analogues of flavone acetic acid: relation with antitumour activityL M Ching, W R Joseph, L Zhuang, et al.Journal of Medicinal Chemistry|December 25, 1992
Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxinsW A Denny, G J Atwell, P B Roberts, et al.Journal of Medicinal Chemistry|April 25, 1997
Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugsB G Siim, G J Atwell, R F Anderson, et al.Cancer Research|August 1, 1984
Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamideB C Baguley, W A Denny, G J Atwell, et al.Pageof 7